Mortality and other adverse outcomes in patients with type 2 diabetes mellitus admitted for COVID-19 in association with glucose-lowering drugs: a nationwide cohort study

Overview of attention for article published in BMC Medicine, November 2020

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 6 X users

Readers on

mendeley: 241 Mendeley

Summary News Policy documents X

So far, Altmetric has seen 2 news stories from 1 outlets.

No mortality benefit found for in-home glucose-lowering medications among those with COVID-19 | 2 Minute Medicine

2 Minute Medicine , 25 Nov 2020

1. In-home glucose-lowering medications were not associated with increased mortality or complications among those with COVID-19.

2 Minute Medicine Rewind November 23, 2020 | 2 Minute Medicine

2 Minute Medicine , 23 Nov 2020

Diaphragm Pathology in Critically Ill Patients With COVID-19 and Postmortem Findings From 3 Medical Centers 1.